Tumor necrosis factor alpha in peripheral neuropathy in type 2 diabetes mellitus

[1] Wooten K(2009)Clinical features and electrodiagnosis of diabetic peripheral neuropathy in the dysvascular patient Phys Med Rehabil Clin N Am 20 657-676

[2] Tesfaye S(2012)Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy Diabetes Metab Res Rev 28 8-14

[3] Selvarajah D(2005)Diabetic neuropathies: a statement by the American Diabetes Association Diabetes Care 28 956-962

[4] Boulton AJ(2013)Beneficial effect of TNF-α inhibition on diabetic peripheral neuropathy J Neuroinflammation 10 69-378

[5] Vinik AI(2005)Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes–the EURODIAB Prospective Complications Study Diabetologia. 48 370-3808

[6] Arezzo JC(2001)Elevated plasma levels of soluble receptors of TNF-alpha and their association with smoking and microvascular complications in young adults with type 1 diabetes J Clin Endocrinol Metab 86 3805-529

[7] Bril V(2005)Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus Clin Endocrinol 63 525-608

[8] Feldman EL(2003)Elevated levels of interleukin-18 and tumor necrosis factor-[alpha ] in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy Metab Clin Exp 52 605-986

[9] Freeman R(2008)Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program Diabetes 57 980-334

[10] Shi X(2001)C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 327-S16

[1] Wooten K(2009)Clinical features and electrodiagnosis of diabetic peripheral neuropathy in the dysvascular patient Phys Med Rehabil Clin N Am 20 657-676

[2] Tesfaye S(2012)Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy Diabetes Metab Res Rev 28 8-14

[3] Selvarajah D(2005)Diabetic neuropathies: a statement by the American Diabetes Association Diabetes Care 28 956-962

[4] Boulton AJ(2013)Beneficial effect of TNF-α inhibition on diabetic peripheral neuropathy J Neuroinflammation 10 69-378

[5] Vinik AI(2005)Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes–the EURODIAB Prospective Complications Study Diabetologia. 48 370-3808

[6] Arezzo JC(2001)Elevated plasma levels of soluble receptors of TNF-alpha and their association with smoking and microvascular complications in young adults with type 1 diabetes J Clin Endocrinol Metab 86 3805-529

[7] Bril V(2005)Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus Clin Endocrinol 63 525-608

[8] Feldman EL(2003)Elevated levels of interleukin-18 and tumor necrosis factor-[alpha ] in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy Metab Clin Exp 52 605-986

[9] Freeman R(2008)Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program Diabetes 57 980-334

[10] Shi X(2001)C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 327-S16